LeMaitre Vascular Inc (Symbol: LMAT) has surpassed the average analyst 12-month target price of $51.75, currently trading at $51.87 per share. This shift prompts potential adjustments in analyst ratings, as they may downgrade due to valuation or raise targets based on positive business developments.
Among the analysts covering LeMaitre, there is a range of target prices with one at $48.00 and another as high as $56.00, resulting in a standard deviation of $3.5. The breakdown of recent analyst ratings shows 2 strong buy ratings, 3 holds, and no sell ratings, maintaining an average rating of 2.2 on a scale where 1 is a strong buy and 5 is a strong sell.
